ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 216 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,468 | -3.3% | 263,900 | -7.3% | 2.19% | +10.6% |
| Q2 2023 | $3,587 | -8.9% | 284,700 | -5.6% | 1.98% | -10.5% |
| Q1 2023 | $3,936 | -26.0% | 301,600 | 0.0% | 2.22% | -28.2% |
| Q4 2022 | $5,320 | -99.9% | 301,600 | -5.2% | 3.08% | +0.5% |
| Q3 2022 | $4,845,000 | -0.1% | 318,100 | -2.8% | 3.07% | +10.2% |
| Q2 2022 | $4,852,000 | -37.8% | 327,200 | -5.5% | 2.79% | -24.4% |
| Q1 2022 | $7,796,000 | +19.4% | 346,200 | -2.2% | 3.69% | +25.2% |
| Q4 2021 | $6,529,000 | +36.1% | 353,900 | -1.4% | 2.94% | +29.0% |
| Q3 2021 | $4,798,000 | -37.8% | 358,900 | -13.9% | 2.28% | -24.7% |
| Q2 2021 | $7,719,000 | +23.2% | 417,000 | -0.1% | 3.03% | +15.4% |
| Q1 2021 | $6,267,000 | -2.6% | 417,400 | -6.3% | 2.63% | -16.4% |
| Q4 2020 | $6,433,000 | – | 445,500 | – | 3.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |